HBV-IN-41

HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].

Product Specifications

CAS Number

[1967002-25-0]

UNSPSC

12352005

Target

HBV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/hbv-in-41.html

Solubility

10 mM in DMSO

Smiles

C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O

Molecular Formula

C18H19ClFN5O3

Molecular Weight

407.83

References & Citations

[1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP1-43378JF585 0.1 mL

Mouse Monoclonal C1qR1/CD93 Antibody (R139) [Janelia Fluor 585]

Ask

View Details

533178-01 30ul

AR discontinued

Ask

View Details

533178-02 100 µL

AR discontinued

Ask

View Details

B6881 96 Tests

Asialoglycoprotein Receptor 2 (ASGR2) Chicken ELISA Kit

Ask

View Details

sc-498675 5 mg

Dipotassium L-Arabinarate

Ask

View Details

RC208502L2V 200 µL

PKC gamma (PRKCG) (NM_002739) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details